General Methods Optical rotations were determined with a DIP-360 digital polarimeter (JASCO, Tokyo, Japan). The pH measurements were carried out on an M-8 pH meter (Horiba, Kyoto, Japan). Melting points were measured with a micro melting point apparatus (Yanagimoto, Kyoto, Japan) and are uncorrected. Lyophilization was carried out with an FD-1 freeze dryer (Tokyo Rika, Tokyo, Japan). A UVIDEC-610C double-beam spectrophotometer (JASCO) was used for the determination of absorbances. HPLC analyses were performed using an 880-PU Intelligent HPLC pump (JASCO), a model 7125 injector (Rheodyne, Cotati, CA, U.S.A.), and a UVIDEC-100V variable-wavelength ultraviolet (UV) detector (JASCO). Preparative HPLC was carried out using a Twincle pump and a VL-611 variable-loop injector (both from JASCO) with an SE-11 refractive index (RI) monitor (Showa Denko, Tokyo, Japan). The columns used were a Finepak SIL-C18 (250 x 4.6 mm i.d.) (JASCO), a YMC-Pack AL-312 ODS (150 x 6 mm i.d.) and a YMC-Pack A-212 C8 (150 x 6 mm i.d.) (both from Yamamura Chemical, Kyoto, Japan). For preparative chromatography, a column packed with LiChroprep RP-18 (5-20 pm, 300 x 20 mm i.d.) (Yamazen, Osaka, Japan) and an Asahipak GS-320 (500 x 7.6 mm i.d.) (Asahi Kasei, Tokyo, Japan) were used.
Solubility Studies Solubility of Glucosyl-CD: Water was carefully added in portions of 0.01-0.1 ml to a glass vessel containing 300 mg of lyophilized glucosyl-CD, and the volume of water required for complete dissolution of the CD within 30 min at 25± 1 °C, by vigorous shaking for 30 s periods at 5-min intervals was measured. For reference, the solubilities of lyophilized a-, /1-, and y-CDs were determined in the same way.
Estimation of Complex-Forming Ability of Glucosyl-CD by the Solubility Method5): Excess amounts of drug were added to aqueous solutions containing various concentrations of CD, and the mixtures were shaken for 24 h at 30 °C to allow equilibration to be attained. Then the aqueous solution was filtered through a 0.2-pm membrane filter and the drug concentraion in the filtrate was determined by HPLC under the conditions shown in Table I . An apparent stability constant, K(M-1), was calculated from the initial straight line portion of the phase solubility diagrams according to the following equation .5) (1)
Preparation of Complexes-
The solid complexes were prepared by mixing equimolecular amounts of a CD and a drug in water. The mixture was shaken at 30 °C for 24 h, and filtered through 0.2-pm membrane filter to remove excess drug, then the filtrate was lyophilized. The freeze-dried samples obtained were used for thermal analysis and Determination of Hemolytic Activity A 0.2% human erythrocytes suspension (1 ml) in 0.1 M isotonic phosphate buffer (pH 7.4, PBS) was added to 1 ml of PBS containing various concentrations of CDs. The mixture was incubated at 37 °C for 30 min and centrifuged at 1300 x g for 10 min. Percent hemolysis was expressed in terms of the ratio of the absorbance at 541 nm of hemoglobin released from erythrocytes with CDs to the absorbance after the complete hemolysis of erythrocytes in water. The hemolytic effects of estriol-G-J3-CD and estriol-2G-/3-CD complexes on human erythrocytes were examined in the same way.
Results and Discussion
Solubility of Glucosyl-CD Solubilities of glucosyl-CDs in water at 25 °C are listed together with data on a-, fi-, and y-CDs (for reference) in Table II as the amount of CD dissolved in 1 ml of water. All three glucosyl-CDs are much more soluble than y-CD, which has been recognized as the most soluble CD. The solubilities of G-fl-CD and 2G-f3-CD are about 50 times and 70 times greater than that of fl-CD, respectively, while that of G-a-CD is higher than that of a-CD by a factor of about 5.
Inclusion Complex-Forming Ability of Glucosyl-CD
The complex-forming ability of three glucosyl-CDs with ten poorly water-soluble (slightly soluble and insoluble) drugs in aqueous solution was studied mainly by the solubility method') and , was compared with that of the parent CDs, a-CD and fl-CD. Since CDs are capable of forming inclusion complexes with compounds having a size compatible, with the dimensions of the cavity,6) the complexation abilities of glucosyl-CDs were almost the same as those of the parent CDs. The apparent stability constant (K), as a tentative measure of inclusion complexation, was estimated from Eq. 1 based on the assumption that a 1 : 1 complex was initially formed. The magnitudes of K values calculated from the initial rising portion of the solubility diagrams were found to be about the same in the two systems of a-CD and G-a-CD, and in the three systems of /3-CD, G-/3-CD, and 2G-fl-CD, as shown in Table III .
However, the enhancement of solubility of poorly water-soluble drug by glucosyl-/3-CDs was much more marked than that by /3-CD, as shown in Table IV . The reason is that most /3-CD systems show typical Bs type solubility curves') and precipitates of the complexes appear, whereas the solubilitites of drugs in G-/3-CD and 2G-/3-CD solutions increase linearly as a function of CD concentration and the solubility curve can be generally classified as being of type A.') Figure 1 shows the phase solubility diagrams obtained for estriol with the three /3-CDs in water at 30 °C, for example. The estriol-/3-CD complex began to precipitate at a /3-CD concentration of 5 x 10 -3 M and therefore the maximum concentration of estriol in /3-CD solution was 3.2 x 10 -3 M ( = 0.7 mg/ml). On the other hand, the solubility of estriol in G-/3-CD or 2G-/3-CD solution linearly increased and estriol concentrations of 5.2 x 10-2 M (= 15.0 mg/ ml) and 5.0 x 10-2 M ( =14.4 mg/ml) were reached in 0.1 M G-/3-CD and 2G-/3-CD solutions, respectively. If necessary, estriol solution of higher concentration than these can be prepared by the use of G-/3-CD or 2G-/3-CD solution of higher concentration (up to 0.7 and 0.9 M, respectively). Interaction of glucosyl-CDs and slightly soluble drugs in aqueous solution was further examined by UV spectroscopy. Figure 2 shows the UV spectra of digitoxin and digitoxigenin in the absence and the presence of G-fl-CD in water. In the absence of G-j3.-CD, digitoxin and digitoxigenin have an absorption maximum at 217 and 220 nm, respectively. On adding G-fl-CD to a digitoxin solution, the absorption maximum is shifted to longer wavelength, while the absorption maximum of digitoxigenin in the presence of G-P-CD remains unchanged at 220 nm. This phenomenon may suggest that the digitoxigenin molecule penetrates into the G-/3-CD cavity from the A-ring side and the lactone-ring (the chromophore) remains outside the cavity, whereas the digitoxin molecule, having a large and hydrophilic group on the A-ring, is included from the opposite side, that is, the lactone ring is incorporated inside the G.-P.-CD 
